Catheter Precision Inc (VTAK) is not a strong buy at the moment given the lack of significant trading trends, neutral technical indicators, and weak financial performance despite revenue growth. For a beginner investor with a long-term strategy, this stock does not currently present a compelling opportunity.

Technical Analysis

The MACD is slightly positive and expanding, which is a mild bullish signal. However, the RSI is neutral at 46.235, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 1.501, with resistance at 1.749 and support at 1.252. Overall, the technical indicators do not suggest a strong buy signal.

Positive Catalysts

Revenue increased significantly by 135.42% YoY in Q3 2025, and gross margin improved to 92.04%, up 2.75% YoY.

Neutral/Negative Catalysts

There is no recent news or significant trading trends from hedge funds or insiders. The stock lacks momentum and has bearish moving averages.

Financial Performance

In Q3 2025, revenue grew significantly by 135.42% YoY to $226,000. However, net income worsened to -$2,251,000, a 45.36% decline YoY. EPS dropped drastically by 95.55% YoY to -1.7. Gross margin improved slightly to 92.04%, up 2.75% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast VTAK stock price to rise

Buy

Hold

Sell

Current: 1.660

Low

Averages

High